Investors Bet On UK/Singapore Biotech To Disrupt Personalized Skin Care

Sequential Skin, whose genetic and microbiome home test kit sells for $149, raised $1.65m in a seed round announced on 11 October. The UK/Singapore biotech will use the funds to roll out the kit in the US while extending its B2B offering to skin care, hair care and health care companies for clinical trial and product validation purposes.

Paulista/Shutterstock.com
• Source: Shutterstock (Shutterstock)

Sequential Skin Ltd. positions its genetic and microbiome analysis as superior to competing diagnostic methods for personalized skin care, and investors are taking notice.

The UK/Singapore biotech startup announced on 11 October that it raised $1

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

Coty’s Next Phase Of ‘All-In To Win’ Strategy Should Generate $130M Savings

 

Coty’s ‘All-in to Win’ program enters the next phase, which sets aggressive savings over the next two years in part by simplifying and scaling its operating model, in addition to boosting its innovation impact.

Cosmetic Industry Deals: ELC/Biotech Partnership Will Further Lauder’s Skin Longevity Push; L’Oréal Cuts Ribbon On $160M US Innovation Center

 

Estee Lauder Companies collaborates with Serpin Pharma to explore anti-inflammatory innovation and skin longevity, while L’Oréal Group celebrates the grand opening of North America Research & Innovation Center with ribbon cutting event.

Unilever CEO’s Sudden Departure Has Investment Community Speculating

 

British consumer goods firm Unilever PLC announces it will replace CEO Hein Schumacher with CFO and Executive Director Fernando Fernandez 1 March.

Coty Establishes ‘Competitive Moat’ For Prestige Fragrance Against Upstarts, ‘Dupes’ – CEO

 

Coty Inc.’s ‘competitive moat’ against upstarts and ‘dupe” competition is a five-step strategy that includes investing in master perfumers over external suppliers and the use of ‘rare, exclusive’ ingredients in scents.

More from Business

Beiersdorf Repositioning In China Will Get Boost From Thiamidol Launch

 

Beiersdorf AG hit some initial bumps with a repositioning of its business in China, but the firm is optimistic about the rollout of Thiamidol Skin Care In 2026.

Revlon Names North American President As Shiseido America CEO Resigns; Beauty News Roundup

 

Revlon Group Holdings LLC announces Dana Medema, formerly VP and head of Personal Health in North America for Philips, will serve as president, North America. Separately, Shiseido Company, Ltd. reports Ron Gee has resigned as Americas Region CEO and will be replaced on an interim basis by Alberto Noe.

L’Oréal, LVMH On First Quarter Challenges

 

L’Oréal Groupe reports in a first quarter presentation that its US business was more challenging than anticipated, while China “was slightly less bad” and Europe represented the best growth contributor. Separately, LVMH's Sephora sees ‘less momentum’ in its US business as competitor Amazon takes an aggressive position on beauty pricing.